RRM2 and cancer: Our initial investigation revealed that aberrantly high RRM2 expression was negatively related to immune activating maker genes in the majority of cancers, whereas it was positively correlated with immunosuppressive genes, indicating that RRM2 regulated the tumor immune microenvironment and immuno-oncological interactions.